$ARIA Headlines Six stocks to watch 4:27 p.m.
Post# of 145157
Posted On: 05/24/2014 9:52:19 AM
$ARIA Headlines
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com
QLT Inc. (QLTI) Catches Eye: Stock Up 8.33% - Tale of the Tape 8:44 a.m. May 23, 2014 - Zacks.com
Ariad Pharmaceuticals' CEO Presents at UBS Global Healthcare Conference (Transcript) 6:59 p.m. May 20, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – NPSP HMSY HGR ARIA 2:00 p.m. May 19, 2014 - InvestorPlace.com
Why the Earnings Streak Will Continue for Ariad Pharmaceuticals (ARIA) - Tale of the Tape 8:51 a.m. May 19, 2014 - Zacks.com
Synergy Pharma Posts Narrower-than-Expected Q1 Loss - Analyst Blog 11:00 a.m. May 14, 2014 - Zacks.com
Investors are Betting Against Ariad Pharmaceuticals (ARIA), Should You? - Tale of the Tape 11:49 a.m. May 13, 2014 - Zacks.com
Wider-than-Expected Q1 Loss at MannKind - Analyst Blog 11:10 a.m. May 13, 2014 - Zacks.com
Tesaro, Inc. (TSRO) Looks Strong as Stock Rallies 21% - Tale of the Tape 8:44 a.m. May 13, 2014 - Zacks.com
PharmAthene (PIP) Catches Eye: Stock Rises 6.4% - Tale of the Tape 9:46 a.m. May 12, 2014 - Zacks.com
Corcept Therapeutics (CORT) in Focus: Stock Rises 5.8% - Tale of the Tape 9:39 a.m. May 12, 2014 - Zacks.com
Spectrum Pharma Up on Q1 Earnings - Analyst Blog 9:00 a.m. May 12, 2014 - Zacks.com
NPS Pharmaceuticals (NPSP) Jumps: Stock Up 13.9% - Tale of the Tape 8:51 a.m. May 12, 2014 - Zacks.com
Ten Analyst Stocks to Buy Under $10 for Big Upside 8:14 a.m. May 10, 2014 - 247WallSt.com
ARIAD's Q1 Loss Narrows - Analyst Blog 12:00 p.m. May 8, 2014 - Zacks.com
Wider-than-Expected Q1 Loss at Nektar - Analyst Blog 11:20 a.m. May 8, 2014 - Zacks.com
ARIAD Pharmaceuticals' (ARIA) CEO Harvey Berger on Q1 2014 Results - Earnings Call Transcript 2:23 p.m. May 7, 2014 - Seeking Alpha
Allergan Beats on Earnings, Guidance Up - Analyst Blog 1:50 p.m. May 7, 2014 - Zacks.com
To Trade or Not to Trade, Part 2.5 11:00 a.m. May 7, 2014 - RealMoney.com
Ariad Pharmaceuticals (ARIA) Stock Falls Despite Revenue Beat 10:51 a.m. May 7, 2014 - TheStreet.com
Notable earnings before Wednesday’s open 5:30 p.m. May 6, 2014 - Seeking Alpha
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF
ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2014 ASCO Annual Meeting 5:15 p.m. May 14, 2014 - BusinessWire - BZX
ARIAD to Present at UBS Global Healthcare Conference 7:35 a.m. May 13, 2014 - BusinessWire - BZX
ARIAD Reports First Quarter 2014 Financial Results and Development Progress 7:35 a.m. May 7, 2014 - BusinessWire - BZX
Active Stocks at a Glance -- Research on American Airlines, American Capital Agency, Akamai Technologies, and ARIAD Pharma 12:24 p.m. May 5, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on First Quarter 2014 Financial Results 7:35 a.m. April 16, 2014 - BusinessWire - BZX
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, Jazz, Ariad, and BioMarin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Mallinckrodt to Buy Drugmaker Questcor Pharmaceuticals for about $5.6B; Tesla Rated "Outperform" by RW Baird 1:00 a.m. April 8, 2014 - ACCESSWIRE
Apollo Education Sinks on Disappointing Earnings; Rubicon Project Makes Grand Debut on NYSE 12:12 a.m. April 3, 2014 - ACCESSWIRE
Clinical Study Initiations, Stock Price Updates, and Strategic Agreements - Analyst Notes on Ariad, Jazz, Intercept, Community Health, and United Technologies 8:00 a.m. April 2, 2014 - PR Newswire - PRF
ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer 7:35 a.m. April 2, 2014 - BusinessWire - BZX
Technical Pointers on Top Gainers -- Research on ARIAD Pharma, Arotech, Restoration Hardware Holdings, and Sprouts Farmers Market 12:52 p.m. March 31, 2014 - PR Newswire - PRF
Newmont Mining Corp Denies Cutting Output; Indonesian Copper and Gold Mine and Ford Raised CEO Alan Mulally's Compensation by 11% 12:16 a.m. March 31, 2014 - ACCESSWIRE
Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America 8:55 a.m. March 25, 2014 - PR Newswire - PRF
ARIAD Announces Initiation of Pivotal Phase 2 ALTA Trial of AP26113 in Patients with Non-Small Cell Lung Cancer 7:35 a.m. March 24, 2014 - BusinessWire - BZX
Financial Results, Clinical Study Updates, Clinical Trial Results, Business Spin-Offs, and New Joint Ventures - Analyst Notes on ARIAD, NewLink, Puma Biotechnology, Theravance, and Ohr Pharmaceutical 8:00 a.m. March 12, 2014 - PR Newswire - PRF
Most Active Equities Technical Snapshot: SandRidge Energy, Ariad Pharma, Groupon, and Vodafone 10:12 a.m. March 11, 2014 - PR Newswire - PRF
New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara 7:24 a.m. March 5, 2014 - PR Newswire - PRF
Workday Upgraded to $150 a Share; Ariad Pharmaceuticals Q4 Loss Widens 12:34 a.m. Feb. 28, 2014 - ACCESSWIRE
ARIAD Reports 2013 Financial Results and Outlines Key Objectives for 2014 7:35 a.m. Feb. 25, 2014 - BusinessWire - BZX
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com
QLT Inc. (QLTI) Catches Eye: Stock Up 8.33% - Tale of the Tape 8:44 a.m. May 23, 2014 - Zacks.com
Ariad Pharmaceuticals' CEO Presents at UBS Global Healthcare Conference (Transcript) 6:59 p.m. May 20, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – NPSP HMSY HGR ARIA 2:00 p.m. May 19, 2014 - InvestorPlace.com
Why the Earnings Streak Will Continue for Ariad Pharmaceuticals (ARIA) - Tale of the Tape 8:51 a.m. May 19, 2014 - Zacks.com
Synergy Pharma Posts Narrower-than-Expected Q1 Loss - Analyst Blog 11:00 a.m. May 14, 2014 - Zacks.com
Investors are Betting Against Ariad Pharmaceuticals (ARIA), Should You? - Tale of the Tape 11:49 a.m. May 13, 2014 - Zacks.com
Wider-than-Expected Q1 Loss at MannKind - Analyst Blog 11:10 a.m. May 13, 2014 - Zacks.com
Tesaro, Inc. (TSRO) Looks Strong as Stock Rallies 21% - Tale of the Tape 8:44 a.m. May 13, 2014 - Zacks.com
PharmAthene (PIP) Catches Eye: Stock Rises 6.4% - Tale of the Tape 9:46 a.m. May 12, 2014 - Zacks.com
Corcept Therapeutics (CORT) in Focus: Stock Rises 5.8% - Tale of the Tape 9:39 a.m. May 12, 2014 - Zacks.com
Spectrum Pharma Up on Q1 Earnings - Analyst Blog 9:00 a.m. May 12, 2014 - Zacks.com
NPS Pharmaceuticals (NPSP) Jumps: Stock Up 13.9% - Tale of the Tape 8:51 a.m. May 12, 2014 - Zacks.com
Ten Analyst Stocks to Buy Under $10 for Big Upside 8:14 a.m. May 10, 2014 - 247WallSt.com
ARIAD's Q1 Loss Narrows - Analyst Blog 12:00 p.m. May 8, 2014 - Zacks.com
Wider-than-Expected Q1 Loss at Nektar - Analyst Blog 11:20 a.m. May 8, 2014 - Zacks.com
ARIAD Pharmaceuticals' (ARIA) CEO Harvey Berger on Q1 2014 Results - Earnings Call Transcript 2:23 p.m. May 7, 2014 - Seeking Alpha
Allergan Beats on Earnings, Guidance Up - Analyst Blog 1:50 p.m. May 7, 2014 - Zacks.com
To Trade or Not to Trade, Part 2.5 11:00 a.m. May 7, 2014 - RealMoney.com
Ariad Pharmaceuticals (ARIA) Stock Falls Despite Revenue Beat 10:51 a.m. May 7, 2014 - TheStreet.com
Notable earnings before Wednesday’s open 5:30 p.m. May 6, 2014 - Seeking Alpha
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF
ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2014 ASCO Annual Meeting 5:15 p.m. May 14, 2014 - BusinessWire - BZX
ARIAD to Present at UBS Global Healthcare Conference 7:35 a.m. May 13, 2014 - BusinessWire - BZX
ARIAD Reports First Quarter 2014 Financial Results and Development Progress 7:35 a.m. May 7, 2014 - BusinessWire - BZX
Active Stocks at a Glance -- Research on American Airlines, American Capital Agency, Akamai Technologies, and ARIAD Pharma 12:24 p.m. May 5, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on First Quarter 2014 Financial Results 7:35 a.m. April 16, 2014 - BusinessWire - BZX
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, Jazz, Ariad, and BioMarin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Mallinckrodt to Buy Drugmaker Questcor Pharmaceuticals for about $5.6B; Tesla Rated "Outperform" by RW Baird 1:00 a.m. April 8, 2014 - ACCESSWIRE
Apollo Education Sinks on Disappointing Earnings; Rubicon Project Makes Grand Debut on NYSE 12:12 a.m. April 3, 2014 - ACCESSWIRE
Clinical Study Initiations, Stock Price Updates, and Strategic Agreements - Analyst Notes on Ariad, Jazz, Intercept, Community Health, and United Technologies 8:00 a.m. April 2, 2014 - PR Newswire - PRF
ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer 7:35 a.m. April 2, 2014 - BusinessWire - BZX
Technical Pointers on Top Gainers -- Research on ARIAD Pharma, Arotech, Restoration Hardware Holdings, and Sprouts Farmers Market 12:52 p.m. March 31, 2014 - PR Newswire - PRF
Newmont Mining Corp Denies Cutting Output; Indonesian Copper and Gold Mine and Ford Raised CEO Alan Mulally's Compensation by 11% 12:16 a.m. March 31, 2014 - ACCESSWIRE
Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America 8:55 a.m. March 25, 2014 - PR Newswire - PRF
ARIAD Announces Initiation of Pivotal Phase 2 ALTA Trial of AP26113 in Patients with Non-Small Cell Lung Cancer 7:35 a.m. March 24, 2014 - BusinessWire - BZX
Financial Results, Clinical Study Updates, Clinical Trial Results, Business Spin-Offs, and New Joint Ventures - Analyst Notes on ARIAD, NewLink, Puma Biotechnology, Theravance, and Ohr Pharmaceutical 8:00 a.m. March 12, 2014 - PR Newswire - PRF
Most Active Equities Technical Snapshot: SandRidge Energy, Ariad Pharma, Groupon, and Vodafone 10:12 a.m. March 11, 2014 - PR Newswire - PRF
New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara 7:24 a.m. March 5, 2014 - PR Newswire - PRF
Workday Upgraded to $150 a Share; Ariad Pharmaceuticals Q4 Loss Widens 12:34 a.m. Feb. 28, 2014 - ACCESSWIRE
ARIAD Reports 2013 Financial Results and Outlines Key Objectives for 2014 7:35 a.m. Feb. 25, 2014 - BusinessWire - BZX
(0)
(0)